Brief: AroCell Reveives Patent In The US
Oct 17 (Reuters) - AroCell AB (publ) AROC.ST :
* REG-PATENT GRANTED IN THE US
* U.S. PATENT AND TRADEMARK OFFICE HAS GRANTED AROCELL'S
PATENT US
10,100,128 TITLED "MONOCLONAL ANTI-TK1 ANTIBODIES"
Source text for Eikon: ID:nGNE4B3nK0
Further company coverage: AROC.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))